Graney & King’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$18.9K Hold
160
0.01% 206
2025
Q4
$26.2K Hold
160
0.02% 181
2025
Q3
$21.4K Hold
160
0.01% 186
2025
Q2
$19.9K Hold
160
0.01% 184
2025
Q1
$20.4K Hold
160
0.02% 178
2024
Q4
$23K Buy
+160
New +$22.9K 0.02% 172

Other funds holding RGEN

Graney & King's RGEN Position: Q1 2026 in Review

Graney & King held its Repligen (RGEN) position steady in Q1 2026 at 160 shares worth $18.9K. The position accounts for 0.01% of the portfolio, ranked #206.

Graney & King first reported a position in RGEN in Q4 2024 and has held it in 6 quarters since. The position peaked at $26.2K in Q4 2025. 441 funds tracked by Wall St. Rank hold RGEN as of Q1 2026.

  • Graney & King held 160 shares of Repligen worth $18.9K as of Q1 2026.
  • Graney & King left its Repligen share count unchanged in Q1 2026.
  • Repligen made up 0.01% of Graney & King's portfolio in Q1 2026, its #206 holding.
  • Graney & King first reported a position in Repligen in Q4 2024 and has held it in 6 quarters since.
  • Graney & King's Repligen position peaked at $26.2K in Q4 2025.
  • 441 funds tracked by Wall St. Rank held Repligen as of Q1 2026.

Based on Graney & King's 13F filing for Q1 2026, filed 18 May 2026.